| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
185,611,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
6,246,627 |
Avg
Vol: |
2,924,823 |
| 52
Week Range: |
$23.99 - $23.99 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Herron Jennifer Lyn |
Exec V.P. Chief Comml Officer |
• – – |
2017-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(450) |
0 |
|
- |
|
| Denner Alexander J |
Director |
– • – |
2017-02-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,850,000) |
0 |
|
- |
|
| Denner Alexander J |
Director |
– • – |
2017-02-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(53,173) |
0 |
|
- |
|
| Denner Alexander J |
Director |
– • – |
2017-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
18,008 |
53,173 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• – – |
2016-03-22 |
4 |
AS |
$6.58 |
$156,871 |
D/D |
(23,834) |
316,212 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$25,871 |
D/D |
(4,000) |
155,088 |
|
- |
|
| Berstein David L |
SVP, Chief IP Counsel |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$15,356 |
D/D |
(2,375) |
262,115 |
|
- |
|
| Fitzgerald Edward M |
Executive VP |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$35,037 |
D/D |
(5,417) |
320,367 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• – – |
2016-03-21 |
4 |
AS |
$6.47 |
$23,116 |
D/D |
(3,575) |
147,011 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
159,088 |
|
- |
|
| Berstein David L |
SVP, Chief IP Counsel |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,750 |
264,490 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• – – |
2016-03-19 |
4 |
AS |
$6.46 |
$23,102 |
D/D |
(3,575) |
135,667 |
|
- |
|
| Cantor Maria E |
SVP, Corporate Affairs |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
139,242 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• – – |
2016-03-19 |
4 |
AS |
$6.47 |
$35,039 |
D/D |
(5,417) |
340,046 |
|
- |
|
| Clackson Timothy P |
President, R&D, CSO |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,833 |
345,463 |
|
- |
|
| Fitzgerald Edward M |
Executive VP |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,833 |
325,784 |
|
- |
|
| Haluska Frank |
SVP, Clinical R&D, CMO |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,500 |
150,586 |
|
- |
|
| Duvall Martin J |
EVP, CCO |
• – – |
2016-03-19 |
4 |
AS |
$6.47 |
$25,867 |
D/D |
(4,000) |
93,039 |
|
- |
|
| Duvall Martin J |
EVP, CCO |
• – – |
2016-03-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,000 |
97,039 |
|
- |
|
| Cole Hugh M |
SVP, Chief Business Officer |
• – – |
2016-03-16 |
4 |
D |
$6.21 |
$15,140 |
D/D |
(2,438) |
5,062 |
|
- |
|
| Cole Hugh M |
SVP, Chief Business Officer |
• – – |
2016-03-16 |
4 |
OE |
$6.21 |
$46,575 |
D/D |
7,500 |
7,500 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-15 |
4 |
D |
$6.18 |
$141,009 |
D/D |
(22,814) |
132,024 |
|
- |
|
| Bollag Daniel M |
Sr. VP, Reg. Affairs & Quality |
• – – |
2016-03-15 |
4 |
OE |
$1.30 |
$4,875 |
D/D |
3,750 |
154,838 |
|
- |
|
| Fitzgerald Edward M |
Executive VP, CFO |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,866 |
D/D |
(9,625) |
314,951 |
|
- |
|
| Berstein David L |
SVP, Chief IP Counsel |
• • – |
2016-03-03 |
4 |
AS |
$6.12 |
$58,887 |
D/D |
(9,625) |
259,740 |
|
- |
|
218 Records found
|
|
Page 1 of 9 |
|
|
